Before transitioning to the pharmaceutical sector, Dr. Kang spent over two decades researching molecular biology at top academic institutes. She holds an extensive track record in executive biotech leadership, successfully spearheading major cross-border R&D transactions and M&A activities. She is dedicated to fostering global expansion and strategic corporate development for biotechnology firms.